Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1.11 USD | +1.83% | +4.72% | -41.27% |
Kurzporträt
Mitarbeiterzahl: 344
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Consumables
30,9
%
| 7 | 24,2 % | 11 | 30,9 % | +65.76% |
Instruments
27,7
%
| 9 | 30,8 % | 10 | 27,7 % | +16.72% |
Services and Other
26,0
%
| 7 | 26,5 % | 9 | 26,0 % | +27.27% |
Software
15,4
%
| 5 | 18,4 % | 6 | 15,4 % | +8.66% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
44,0
%
| 12 | 42,0 % | 16 | 44,0 % | +36.09% |
EMEA
35,9
%
| 9 | 32,2 % | 13 | 35,9 % | +44.68% |
China
10,0
%
| 1 | 2,5 % | 4 | 10,0 % | +418.01% |
Americas
5,9
%
| 2 | 7,9 % | 2 | 5,9 % | -2.57% |
Asia Pacific
4,2
%
| 4 | 15,4 % | 2 | 4,2 % | -64.48% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Robert Holmlin
CEO | Chief Executive Officer | 56 | 12.01.11 |
Gülsen Kama
DFI | Director of Finance/CFO | 51 | 11.09.23 |
Shroff Hema
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hastie Alex
CTO | Chief Tech/Sci/R&D Officer | - | - |
Alka Chaubey
CTO | Chief Tech/Sci/R&D Officer | 51 | 31.08.20 |
Mark Oldakowski
COO | Chief Operating Officer | 50 | 01.10.14 |
Marin Stanislas
SAM | Sales & Marketing | - | - |
Jonathan Dixon
LAW | General Counsel | - | 01.01.23 |
Helene Klein
HRO | Human Resources Officer | - | 14.02.22 |
Mark Adamchak
AUD | Comptroller/Controller/Auditor | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 64 | 01.07.18 | |
David Barker
CHM | Chairman | 82 | 11.05.10 |
Albert Luderer
BRD | Director/Board Member | 75 | 01.10.11 |
Robert Holmlin
CEO | Chief Executive Officer | 56 | 12.01.11 |
Kristiina Vuori
BRD | Director/Board Member | 56 | 06.06.19 |
Hannah Mamuszka
BRD | Director/Board Member | 47 | 04.05.20 |
Director/Board Member | - | 17.02.22 | |
Yvonne Linney
BRD | Director/Board Member | 62 | 04.05.20 |
Vincent J. Wong
BRD | Director/Board Member | - | 22.12.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 54 694 000 | 54 433 586 ( 99,52 %) | 0 | 99,52 % |
Unternehmenskontakt
Bionano Genomics, Inc.
9540 Towne Centre Drive Suite 100
92121, San Diego
+858 888 7600
http://www.bionanogenomics.comSektor
Umsatz nach Geschäftsbereich
Umsatz je Region
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-41.27% | 60.71 Mio. | |
+9.50% | 222 Mrd. | |
+7.95% | 185 Mrd. | |
+18.30% | 141 Mrd. | |
+18.47% | 100 Mrd. | |
+7.83% | 68.36 Mrd. | |
+25.32% | 57.52 Mrd. | |
-3.69% | 46.84 Mrd. | |
+4.66% | 42.64 Mrd. | |
+15.12% | 29.09 Mrd. |
- Börse
- Aktien
- Aktie Bionano Genomics, Inc. - Nasdaq
- Unternehmen Bionano Genomics, Inc.